Drreddys Laboratories | RDY - Ebit


Drreddys Laboratories reported INR3.05B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Aurora Cannabis CAD 7.12M 42.91M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Canopy Growth CAD -145.65M 132.99M Mar/2026
Cipla INR 8.88B 2.74B Jun/2026
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Drreddys Laboratories INR 3.05B 13.32B Mar/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Lonza CHF 673M 54M Jun/2025
Novartis USD 4.73B 549M Jun/2026
Pacira USD 9.96M 5.33M Jun/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Richter Gedeon HUF 62.32B 1.26B Mar/2026
Sun Pharmaceuticals INR 35.57B 802.7M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026